Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain.
Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis.
Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Neuro-Endocrine Networks Controlling Immune System in Health and Disease.
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.
A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.
Fast myelin water fraction estimation using 2D multislice CPMG.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
New EMA Advice for PML Prevention With Fingolimod in MS
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
A MS-lesion pattern discrimination plot based on geostatistics.
Neuroimaging evidence of deficient axon myelination in Wolfram syndrome.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis: Results From a United States Network.
Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
Neuromyelitis optica-like pathology is dependent on Type I interferon response.
Pages
« first
‹ previous
…
525
526
527
528
529
530
531
532
533
…
next ›
last »